Experimental antibody 'cocktail' protects animals from three deadly Ebola viruses - Mapp Biopharmaceutical, Inc.

Mapp Biopharmaceutical

Press Inquiries

About Us
Product Development
News
- In the News
- Press Releases
Publications
Job Openings
Expanded Access Policy
Contact Us

antibody

Search for:

Archives

October 2022
January 2021
June 2019
January 2019
September 2018

Categories

Press Releases

Recent News

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease

Oct 27, 2022

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease To further enhance preparedness against health security threats, BARDA is extending a partnership with Mapp...

ASPR awards $110 million to advance development, procure therapeutic for Sudan ebolavirus

Oct 4, 2022

ASPR awards $110 million to advance development, procure therapeutic for Sudan ebolavirus The Administration for Strategic Preparedness and Response (ASPR) today announced a $109.8 million contract with Mapp Biopharmaceutical Inc., for the advanced...

Additional Information

FCOI Policy
Purchase Order Terms and Conditions
Pay Transparency Nondiscrimination Provision
Equal Employment Opportunity
Institutional Biosafety Committee (NIH)
Equal Employment Opportunity and Affirmative Action Policy Statement

Jobs Opportunities

© 2017-2023 Mapp Biopharmaceutical. All Rights Reserved.